Home
about us
Company Profile
factory tour
quality control
products

Homes Prefab

Modern Modular Homes

Modern Prefab Houses

Tirzepatide Weight Loss

Custom Prefab Homes

Star Dome Tent

Outdoor Yoga Tent

Transparent Dome Tent

Clear Plastic Outdoor Dome

Single Dome Tent

Double Dome Tent

Glamping Dome Tent

Building Materials
video
events
news
cases
contact us
quote
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
home
about us
products

Homes Prefab

Modern Modular Homes

Modern Prefab Houses

Tirzepatide Weight Loss

Custom Prefab Homes

Star Dome Tent

Outdoor Yoga Tent

Transparent Dome Tent

Clear Plastic Outdoor Dome

Single Dome Tent

Double Dome Tent

Glamping Dome Tent

Building Materials
video
events
news
cases
contact us
quote
banner banner

News Details
Home > News >

Company news about Progress in weight management of Tirzepatide in 2024

Events

news

Cases
Contact Us
Mr. Will
18565816114@163.com
86-0755-88881688
Contact Now

Progress in weight management of Tirzepatide in 2024

2025-01-20

Progress in weight management of Tirzepatide in 2024
The latest study data show that Tirzepatide's weight loss effect in non-diabetic obese people exceeds that of traditional GLP-1 receptor agonists. The results showed that more than 50 percent of patients treated with Tirzepatide lost more than 10 percent of their body weight, and some patients lost more than 20 percent of their body weight. This result further strengthens the potential of Tirzepatide as a treatment for obesity and may lead to further indication approval for obesity treatment in the future.

banner
News Details
Home > News >

Company news about-Progress in weight management of Tirzepatide in 2024

Events

News

Cases

Progress in weight management of Tirzepatide in 2024

2025-01-20

Progress in weight management of Tirzepatide in 2024
The latest study data show that Tirzepatide's weight loss effect in non-diabetic obese people exceeds that of traditional GLP-1 receptor agonists. The results showed that more than 50 percent of patients treated with Tirzepatide lost more than 10 percent of their body weight, and some patients lost more than 20 percent of their body weight. This result further strengthens the potential of Tirzepatide as a treatment for obesity and may lead to further indication approval for obesity treatment in the future.

+8618331293985
Quick link
Home About us products Video news Cases Contact Us
Quick Contact

Address

5F 501, Block B, Qixing Commercial Plaza, Intersection of Meilong Road and Minwang Road, Minzhi Street, Longhua District,Shenzhen

Tel

86-0755-88881688

+8618331293985
Our Newsletter
Subscribe to our newsletter for discounts and more.
Privacy Policy |  Sitemap  | China Good Quality Homes Prefab Supplier. Copyright © 2024-2025 Shenzhen Ayou Technology Co., Ltd. . All Rights Reserved.